1. World Health Organization. International Agency for Research on Cancer. Globocan 2018. All cancers incidence and mortality. 2018 [cited 24.05.2020]. Available from URL: https://gco.iarc.fr/today/data/factsheets/cancers/39-All-cancers-fact-sheet.pdf.
2.
National Cancer Institute. Cancer Screening Overview (PDQVR) – Health Professional Version. 2017 [cited 24.05.2020]. Available from URL: https://www.cancer.gov/about-cancer/screening/hp-screening-overview-pdq.
3.
The Global Cancer Observatory. Poland. Fact sheet 2018 [cited 25.05.2020]. Available from URL: https://gco.iarc.fr/today/data/factsheets/populations/616-poland-fact-sheets.pdf.
4.
World Health Organization. Regional Office for Europe. Screening programmes: a short guide. Increase effectiveness, maximize benefits and minimize harm 2020 [cited 16.05.2020]. Available from URL: https://apps.who.int/iris/handle/10665/330829.
5.
Sarma EA, Silver MI, Kobrin SC, et al. Cancer screening: health impact, prevalence, correlates, and interventions. Psychol Health 2019; 34(9): 1036–1072.
6.
The Council of the European Union. Council Recommendation of 2 December 2003 on cancer screening (2003/878/EC) 2003 [cited 24.05.2020]. Available from URL: https://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2003:327:0034:0038:EN:PDF.
7.
Jansen EEL, Zielonke N, Gini A, et al. Effect of organised cervical cancer screening on cervical cancer mortality in Europe: a systematic review. Eur J Cancer 2020; 127: 207–223.
8.
Gini A, Jansen EEL, Zielonke N, et al. Impact of colorectal cancer screening on cancer-specific mortality in Europe: a systematic review. Eur J Cancer 2020; 127: 224–235.
9.
Zielonke N, Gini A, Jansen EEL, et al. Evidence for reducing cancer-specific mortality due to screening for breast cancer in Europe: a systematic review. Eur J Cancer 2020; 127: 191–206.
10.
Emery JD, Shaw K, Williams B, et al. The role of primary care in early detection and follow-up of cancer. Nat Rev Clin Oncol 2014; 11(1): 38–48.
11.
Narodowy Fundusz Zdrowia. Programy profilaktyczne [cited 19.12.2020]. Available from URL: https://www.nfz.gov.pl/dla-pacjenta/programy-profilaktyczne/ (in Polish).
12.
World Health Organization. International Agency for Research on Cancer. CanScreen5 [cited 24.05.2020]. Available from URL: https://canscreen5.iarc.fr.
13.
Minister Zdrowia. Profilaktyka raka jelita grubego [cited 19.12.2020]. Available from URL: http://www.archiwum.mz.gov.pl/zdrowie-i-profilaktyka/narodowy-program-zwalczania-chorob-nowotworowych/profilaktyka-raka-jelita-grubego/ (in Polish).
14.
Program Badań Przesiewowych Raka Jelita Grubego. Zgłaszalność w latach 2012–2017 [cited 16.05.2020]. Available from URL: http://pbp.org.pl/wp-content/uploads/2018/03/Zg%C5%82aszalno%C5%9B%C4%87_2012-2017-1.pdf (in Polish).
15.
Karsa L, Patnick J, Segnan N, eds. European guidelines for quality assurance in colorectal cancer screening and diagnosis. European Commission, Directorate-General for Health and Consumers, Executive Agency for Health and Consumers, World Health Organization, Publications Office; 2010.
16.
Baxter NN, Sutradhar R, Li Q, et al. Do Primary Care Provider Strategies Improve Patient Participation in Colorectal Cancer Screening. Am J Gastroenterol 2017; 112(4): 622–632.
17.
Beaber EF, Tosteson ANA, Haas JS, et al. Breast cancer screening initiation after turning 40 years of age within the PROSPR consortium. Breast Cancer Res Treat 2016; 156(1): 109–116.
18.
Brenner AT, Dougherty M, Reuland DS. Colorectal Cancer Screening in Average Risk Patients. Med Clin North Am 2017; 101(4): 755–767.
19.
Buist DSM, Gao H, Anderson ML, et al. Breast cancer screening outreach effectiveness: mammogram-specific reminders vs. comprehensive preventive services birthday letters. Prev Med 2017; 102: 49–58.
20.
Carney TJ, Morgan GP, Jones J, et al. Hypothesis generation using network structures on community health center cancer-screening performance. J Biomed Inform 2015; 57: 288–307.
21.
Chuang E, Pourat N, Chen X, et al. Organizational Factors Associated with Disparities in Cervical and Colorectal Cancer Screening Rates in Community Health Centers. J Health Care Poor Underserved 2019; 30(1): 161–181.
22.
Clouston K, Katz A, Martens PJ, et al. Does access to a colorectal cancer screening website and/or a nurse-managed telephone help line provided to patients by their family physician increase fecal occult blood test uptake? Results from a pragmatic cluster randomized controlled trial. BMC Cancer 2014; 14(1): 263.
23.
Deding U, Henig AS, Torp-Pedersen C, et al. The effects of reminders for colorectal cancer screening: participation and inequality. Int J Colorectal Dis 2019; 34(1): 141–150.
24.
Everett T, Bryant A, Griffin MF, et al. Interventions targeted at women to encourage the uptake of cervical screening. Cochrane Database Syst Rev 2011; 2011(5): CD002834.
25.
Gimeno Garcia AZ, Hernandez Alvarez Buylla N, Nicolas-Perez D, et al. Public awareness of colorectal cancer screening: Knowledge, attitudes, and interventions for increasing screening uptake. ISRN Oncol 2014; 2014: 425787.
26.
Giordano L, Stefanini V, Senore C, et al. The impact of different communication and organizational strategies on mammography screening uptake in women aged 40–45 years. Eur J Public Health 2012; 22(3): 413–418.
27.
Goldzweig CL, Parkerton PH, Washington DL, et al. Primary care practice and facility quality orientation: influence on breast and cervical cancer screening rates. Am J Manag Care 2004; 10(4): 265–272.
28.
Ingrand I, Defossez G, Richer J-P, et al. Colonoscopy uptake for high-risk individuals with a family history of colorectal neoplasia: a multicenter, randomized trial of tailored counseling versus standard information. Medicine 2016; 95(33): e4303-e.
29.
Kitchener HC, Gittins M, Rivero-Arias O, et al. A cluster randomised trial of strategies to increase cervical screening uptake at first invitation (STRATEGIC). Health Technol Assess 2016; 20(68): 1–138.
30.
Krok-Schoen JL, Oliveri JM, Paskett ED. Cancer care delivery and women’s health: the role of patient navigation. Front Oncol 2016; 6: 2.
31.
Lin SC, McKinley D, Sripipatana A, et al. Colorectal cancer screening at US community health centers: Examination of sociodemographic disparities and association with patient-provider communication. Cancer 2017; 123(21): 4185–4192.
32.
MacLaughlin KL, Swanson KM, Naessens JM, et al. Cervical cancer screening: a prospective cohort study of the effects of historical patient compliance and a population-based informatics prompted reminder on screening rates. J Eval Clin Pract 2014; 20(2): 136–143.
33.
Molina Y, Kim SJ, Berrios N, et al. Patient Navigation Improves Subsequent Breast Cancer Screening After a Noncancerous Result: Evidence from the Patient Navigation in Medically Underserved Areas Study. J Womens Health (Larchmt) 2018; 27(3): 317–323.
34.
Offman J, Wilson M, Lamont M, et al. A randomised trial of weekend and evening breast screening appointments. Br J Cancer 2013; 109(3): 597–602.
35.
Percac‐Lima S, López L, Ashburner JM, et al. The longitudinal impact of patient navigation on equity in colorectal cancer screening in a large primary care network. Cancer 2014; 120(13): 2025–2031.
36.
Peterson EB, Ostroff JS, DuHamel KN, et al. Impact of provider-patient communication on cancer screening adherence: a systematic review. Prev Med 2016; 93: 96–105.
37.
Raine R, Duffy SW, Wardle J, et al. Impact of general practice endorsement on the social gradient in uptake in bowel cancer screening. Br J Cancer 2016; 114(3): 321–326.
38.
Robinson-White S, Conroy B, Slavish KH, et al. Patient navigation in breast cancer: a systematic review. Cancer Nurs 2010; 33(2): 127–140.
39.
Sabatino SA, Lawrence B, Elder R, et al. Effectiveness of interventions to increase screening for breast, cervical, and colorectal cancers: nine updated systematic reviews for the guide to community preventive services. Am J Prev Med 2012; 43(1): 97–118.
40.
Stone EG, Morton SC, Hulscher ME, et al. Interventions that increase use of adult immunization and cancer screening services: a meta-analysis. Ann Intern Med 2002; 136(9): 641–651.
41.
Underhill ML, Kiviniemi MT. The association of perceived provider–patient communication and relationship quality with colorectal cancer screening. Health Educ Behav 2012; 39(5): 555–563.
42.
Yano EM, Soban LM, Parkerton PH, et al. Primary care practice organization influences colorectal cancer screening performance. Health Serv Res 2007; 42(3 Pt 1): 1130–1149.
43.
Abadi MMM, Vakilian K, Safari V. Motivational interview on having Pap test among middle-aged women – a counseling service in primary care. Fam Med Prim Care Rev 2018; 20(2): 101–105.
44.
Helfrich CD, Simonetti JA, Clinton WL, et al. The association of team-specific workload and staffing with odds of burnout among VA primary care team members. J Gen Intern Med 2017; 32(7): 760–766.
45.
Wells KJ, Battaglia TA, Dudley DJ, et al. Patient navigation: state of the art or is it science? Cancer 2008; 113(8): 1999–2010.
46.
Paskett ED, Harrop JP, Wells KJ. Patient navigation: an update on the state of the science. CA Cancer J Clin 2011; 61(4): 237–249.
47.
Vries EF de, Struijs JN, Heijink R, et al. Are low-value care measures up to the task? A systematic review of the literature. BMC Health Serv Res 2016; 16(1): 405.
48.
Isaac T, Rosenthal MB, Colla CH, et al. Measuring overuse with electronic health records data. Am J Manag Care 2018; 24(1): 19–25.
49.
Kruzikas D, Smith JS, Harley C, et al. Costs Associated with Management of Cervical Human Papillomavirus-Related Conditions. Cancer Epidemiol Biomarkers Prev 2012; 21(9): 1469–1478.
50.
Verkerk EW, Tanke MAC, Kool RB, et al. Limit, lean or listen? A typology of low-value care that gives direction in de-implementation. Int J Qual Health Care 2018; 30(9): 736–739.
51.
Sirocco. SCIROCCO Maturity Model for Integrated Care [cited 19.12.2020]. Available from URL: https://www.scirocco-project.eu/maturitymodel/.
52.
Luxford K, Safran DG, Delbanco T. Promoting patient-centered care: a qualitative study of facilitators and barriers in healthcare organizations with a reputation for improving the patient experience. Int J Qual Health Care 2011; 23(5): 510–515.
